Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-25-018704
Filing Date
2025-04-22
Accepted
2025-04-22 06:07:18
Documents
4
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A fy2024def14aproxystatement.htm DEF 14A 477050
2 primelogo.jpg GRAPHIC 6203
3 proxycard1.jpg GRAPHIC 100489
4 proxycard2.jpg GRAPHIC 91605
  Complete submission text file 0001628280-25-018704.txt   751504
Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41536 | Film No.: 25854875
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)